Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
7
-
Price
-
$488.28
Significant Holders of REGENERON PHARMACEUTICALS - COM - Call as of Q1 2020
9 filings reported holding 75886F907 - REGENERON PHARMACEUTICALS - COM - Call as of Q1 2020.
REGENERON PHARMACEUTICALS - COM - Call has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of shares
.
Largest 9 shareholders include IMC-Chicago, LLC (50.1K shares), SG Americas Securities, LLC (22K shares), JPMORGAN CHASE & CO (15.5K shares), MARK ASSET MANAGEMENT LP (5K shares), Allianz Asset Management GmbH (4.1K shares), GROUP ONE TRADING, L.P. (3.8K shares), SIMPLEX TRADING, LLC (734 shares), FLAGSHIP HARBOR ADVISORS, LLC (0 shares), and HBK INVESTMENTS L P (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.